Immediate Impact
2 by Nobel laureates 1 from Science/Nature 59 standout
Citing Papers
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Harrah Chiang being referenced
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Harrah Chiang | 77 | 5 | 81 | 41 | 5 | 124 | |
| Joanne Leung | 92 | 6 | 41 | 103 | 6 | 157 | |
| Alice Newey | 80 | 5 | 60 | 60 | 4 | 109 | |
| Amanda J. Rode | 56 | 6 | 40 | 27 | 4 | 80 | |
| Bryant Harbourne | 80 | 12 | 91 | 75 | 6 | 184 | |
| Stephen J. Luen | 103 | 3 | 60 | 43 | 7 | 136 | |
| Simone Ostrouska | 71 | 3 | 47 | 85 | 5 | 132 | |
| Adelyn Wise | 68 | 3 | 84 | 16 | 5 | 106 | |
| Lloyd Bod | 94 | 8 | 36 | 126 | 5 | 177 | |
| Syed O. Ali | 90 | 4 | 77 | 27 | 5 | 131 | |
| Natalia Pieper | 60 | 8 | 42 | 57 | 6 | 103 |
All Works
Loading papers...